Skip to main content


Latest articles

Three risk factors for CAH hospitalisation identified

Endocrine Society publishes paediatric obesity management guidelines

Weight loss and vascular benefits sustained after bariatric surgery in adolescence

Conservative surgery pays dividends for paediatric craniopharyngioma sequelae

KIGS data confirm male predominance in treated GH disorders

‘Surgical dogma’ challenged for paediatric well-differentiated thyroid carcinoma

Skeletal complications common in aggrecan gene-related short stature

Turner syndrome influences Hashimoto thyroiditis prognosis

25-11-2016 | HBV | News | Article

Screening for metabolic syndrome warranted in chronic hepatitis B

Metabolic syndrome increases the risk for cardiovascular events in patients with chronic hepatitis B virus infection, study findings indicate.


Hepatology 2016; 64: 1507–1517

Aromatase inhibitors enhance growth in GH-treated adolescent boys

SHOX deletions most deleterious in females

05-10-2016 | Oncology | News | Article

News in brief

Thyroid function linked to cancer risk

Elevated levels of free thyroxine are associated with an increased risk of developing cancer.

Letrozole effective for girls with McCune-Albright syndrome and precocious puberty

Broader approach needed for genetic prediction of growth response to rhGH

Early gonadotrophin replacement may optimise outcomes for HH adolescents

Prematurity should not discourage genetic testing in hyperglycaemic newborns

04-08-2016 | Oncology | News | Article

Nonfunctional adrenal tumours raise diabetes risk

Individuals with nonfunctional adrenal tumours (NFATs) have a nearly twofold increased risk of incident diabetes relative to those without adrenal tumours, shows research published in the Annals of Internal Medicine.


Ann Intern Med 2016; Advance online publication

‘Mini-puberty’ linked to growth velocity in infancy

24-hour urinary free cortisol pinpoints paediatric Cushing’s syndrome

27-06-2016 | Diabetes | News | Article

Editor's pick

Pioglitazone effective in diabetes patients with NASH

Pioglitazone may halt the progression of nonalcoholic steatohepatitis in patients with prediabetes or Type 2 diabetes, a randomised trial shows.


Ann Intern Med 2016; Advance online publication

image credits